4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, T; Manabe, T | 1 |
| Endo, Y; Kazama, M; Kobayashi, K; Miyajima, Y; Nakatani, T; Tahara, C; Tajimi, K; Tanaka, H | 1 |
2 other study(ies) available for 4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate and Disease Models, Animal
| Article | Year |
|---|---|
Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Topics: Acute Disease; Animals; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Guanidines; Male; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Taurocholic Acid | 1992 |
[Improving effect of the synthetic protease inhibitor E-3123 on experimental DIC in dogs].
Topics: Animals; Blood Coagulation Tests; Disease Models, Animal; Disseminated Intravascular Coagulation; Dogs; Gabexate; Guanidines; Hemodynamics; Lactates; Lactic Acid; Liver; Pyruvates; Pyruvic Acid | 1992 |